LAD603

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAD603, covering 2025-12-17 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LAD603 in Adults With Alopecia Areata [Phase 2]